Oryza Pharmaceuticals Inc. is a privately owned company, with primary operations based in Coral Springs, Florida, USA. We engage in the development, manufacture, marketing, distribution and sale of generic pharmaceutical products primarily in the United States. Oryza combines over 120 years of R&D knowledge and experience to offer a broad and integrated portfolio of products and services to the global pharmaceutical industry. We are dedicated to developing affordable branded and generic pharmaceutical products of high efficacy, safety and quality.

Oryza believes in the power of collaboration.  We proactively seek out and work with a network of selected partners to build a comprehensive portfolio of meaningful products for our customers.

Our Mission

Providing the highest quality products through technical innovation, experienced leadership and outstanding customer service. Our values center around product quality, ethical behavior and integrity in all our relationships.

Management Team

Management Team

The breadth and depth of our industry experience is one of our biggest strengths. With over 200 years of combined experiences, our management team is comprised of a group of talented industry professionals with deep expertise in the areas of drug delivery technologies, pharmaceutical product development, clinical studies, quality control, process scale-up and manufacturing, compliance, regulatory affairs, and sales and marketing.

Technological Innovation Focused

Oryza focuses on high-value and difficult-to-develop solid oral and alternative dosage form ANDAs and 505(b)(2). We develop and commercialize drug products that fulfill unmet medical needs across a broad range of therapeutic areas. Through our technical expertise, our development process utilizes sophisticated drug delivery technologies that include extended release, tamper-resistance and as well as other niche product solutions.